US/UK/Canada

Share

Pick a time period -

Observe Medical ASA: Interim report first quarter 2021

Oslo, May 12[th], 2021 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the first quarter 2021, reporting continued advancement for the commercialization and go-to-market strategy Sippi®, a unique and proprietary solution for digital automated urine monitoring in hospitals. “We are continuing to execute on our go-to-market strategy, with current focus on the clinical rollout of Sippi® in the Nordics and Europe, and so far this year, we have made considerable steps forward, despite the challenging environment with highly restricted access to our customers. It is

Observe Medical ASA : Invitation to first quarter 2021 presentation

Observe Medical ASA invites you to a presentation of the first quarter 2021 on Wednesday May 12 at 8.30 CET. Due to the covid-19 situation the presentation will be held as a webcast only. The event will start at 08.30 CET and will be webcasted on www.observemedical.com - Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210512_3/ Representatives from the Company will be: CEO Björn Larsson and CFO Per Arne Nygård. Viewers are welcome to ask written questions during and after the presentation through the webcast player.

Observe Medical – Nya Karolinska Sjukhuset initiates new studies to broaden the clinical scope of use for Sippi®

Oslo May 07, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Nya Karolinska Sjukhuset, Sweden, prepares new studies to broaden the clinical scope of use for Sippi® automated, digital urine measurement system, building further on the results from the recent dissertation by Dr Martin Slettengren. Following the recent dissertation by Dr. Martin Slettengren, ”Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation due to proteinuria, hemoglobinuria and bacterial growth”, the team at thorax Intensive Care Unit at Nya Karolinska Sjukhuset, led

Observe Medical further expands and strengthens the global patent protection for Sippi® proprietary technology

Oslo May 6, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Sippi® automated and digital urine meter recently received new patent approvals in India, China and Brazil, further expanding and strengthening the global patent protection for Sippi® proprietary technology. “We are pleased to announce that Sippi® since end March this year, has received three important patent approvals - in India, China and Brazil respectively, for SippCoat® and SippSense® proprietary technologies, thus further strengthening the patent protection and supporting the current commercial rollout in Europe as

Observe Medical ASA: Notice of Annual General Meeting

Oslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, May 21, 2021 at 09:00 (CET) in the Observe Medical offices in Henrik Ibsens gate 90 (3rd floor), 0255 Oslo.  The Notice of the Annual General Meeting is attached. Due to the restrictions caused by Covid-19 and advice from the Norwegian authorities in connection therewith, all shareholders are encouraged to exercise their shareholder rights without physical attendance at the General Meeting. The Notice is posted electronically or by mail to all shareholders and is

Observe Medical ASA - Annual report 2020

Oslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): Attached Observe Medical ASA`s annual report for 2020. The report is also available on the company's website, www.observemedical.com The annual report was reviewed and approved by the board of directors on April 29, 2021. The financial statements included in the annual report has no significant changes since the preliminary results for the full year 2020 reported on February 23, 2021. For further information, please contact: Björn Larsson, CEO. Mobile: +46 76 620 17 25 E-mail: bjorn.larsson@observemedical.com Per Arne

Observe Medical receives follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market

Oslo 22 March 2021 – Observe Medical ASA (OSE: OBSRV), today announces that Observe Medical Group has received a follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market. The follow-up order represents a value of 4.2 mSEK, with planned delivery of the products during Q3 this year. The original order, with a value of 5.8 mSEK was announced on January 29 see Link . Thus, the total order

Observe Medical: Delivering blood & fluid warmer systems to three Nordic hospitals

Oslo 8 March 2021 – Observe Medical ASA (OSE: OBSERV), today announces an order to deliver a newly introduced blood & fluid warmer system, including disposable supplies, to two university hospitals and one regional hospital in Nordic market.  “This is a breakthrough order for an innovative and newly introduced blood & fluid warmer system and the result of the work by our sales team and the strong relations with our customers. The order includes a number of the blood & fluid warmer devices and the contract for supply of the disposable single patient blood warmer sets for several years,

Observe Medical ASA: Interim report fourth quarter 2020

Oslo, February 23[rd], 2020 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the fourth quarter 2020, reporting continued progress in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “Sippi® contributes to improved clinical outcome for hospitalized patients, enhances the working situation for health care professionals and drives efficiency for clinics. During Q4 2020 and the beginning of 2021 we have brought more systems into clinical

Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit

Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19    As a result of the recent improvements of the Covid-19 situation at the hospital, the Department of Cardiothoracic Anaesthesiology and Intensive Care at Nya Karolinska Sjukhuset, has decided to resume the implementation of Sippi® in clinical use. The implementation will start in February, and will be done in a stepwise manner, with a

Observe Medical ASA : Invitation to fourth quarter 2020 presentation

Observe Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com - Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/ Representatives from the Company will be: CEO Björn Larsson and CFO Per Arne Nygård. Viewers are welcome to ask written questions during and after the presentation through the webcast player.

Observe Medical – Sippi® installed in clinical use at ICU department at major hospital in Northern Italy

Oslo February 12, 2021 – Observe Medical ASA (OSE: OBSERV), announces that a major hospital in Northern Italy has equipped the ICU department with Sippi® systems in clinical use, the result of the close collaboration with Observe Medical distributor in Italy, SIM Italia. As a result of the strengthened partnership in 2020 with the distributor SIM Italia and the subsequent close collaboration to prepare the launch of Sippi®, a major hospital in Northern Italy has now installed Sippi® systems in clinical use at the ICU department. “We are pleased to announce that our close collaboration

Observe Medical ASA - Strengthened presence in Norway through collaborations with Yallow Life Science AS and Norway Health Tech

Oslo February 4, 2021 – Observe Medical ASA (OSE: OBSERV), announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech.   Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe. The short-term focus is the acceleration of Sippi® in clinical use in the Nordics, and to further strengthen the presence in Norway, Observe Medical is now entering a collaboration with the medtech focused

Observe Medical receives significant order for medical consumables from a hospital region in the Nordic market

Oslo 29 January 2021 – Observe Medical ASA (OSE: OBSERV), today announces that Observe Medical Group has received a significant order for medical consumables from a hospital region in the Nordic market. Following the recent acquisition and integration of Sylak AB, Observe Medical has delivered strong sales performance and today announces a significant order for delivery of safety needles to a hospital region in the Nordic market. The current order represents a value of 5.8 mSEK, with delivery of the products during April and May 2021, with potential for further orders later in 2021. “

Observe Medical ASA - Doctoral dissertation further demonstrates clinical benefits of Sippi®

Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation due to proteinuria, hemoglobinuria and bacterial growth’ is written by Dr. Martin Slettengren and was dissertated at Dept. of Molecular Medicine and Surgery, Karolinska Institute in Stockholm on January 14,

Observe Medical ASA – Enhanced Nordic sales team in full operations, driving Sippi® clinical use in the Nordics, following the recent acquisition of Sylak AB

Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market. Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe, with the near-term focus of accelerating Sippi clinical use in Nordics. Therefore, the access to Sippi target customers is key, specifically important during the current pandemic, since the access to healthcare professionals is

Observe Medical ASA: Interim report third quarter 2020

Oslo, November 3rd, 2020 - Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes to improved clinical results for patients and increased efficiency for the health care system. For us, it is now paramount to roll the Sippi® system out to hospitals, and through the acquisition of Sylak AB,

Observe Medical ASA : Invitation to third quarter 2020 presentation

Observe Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com - Investor relations and on the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding infection control considerations, we encourage all to follow the presentation on the webcast and not in physical presence.   Representatives from the Company will be: CEO Björn

Observe Medical ASA – Closing of the transaction to acquire Sylak AB completed.

Observe Medical ASA, October 30, 2020: On October 29, 2020, Observe Medical announced the signing of the final agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). All conditions in the agreement is met, and the transaction closed on October 30, 2020.  “We are happy to finally conclude this important transaction for Observe Medical and to be welcoming the Sylak team. They will be important in accelerating the Nordic go-to-market strategy for Observe Medical’s main

Observe Medical ASA – Final agreement to acquire Sylak AB signed

Observe Medical ASA, October 29, 2020: Reference is made to Observe Medical’s announcement October 16, 2020 regarding the signing of a letter of intent to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). Today, Observe Medical and the seller, ABIGO Medical AB, signed the final sale and purchase agreement with main terms as announced October 16. The transaction is expected to close tomorrow, 30 October 2020. “The transaction will strengthen Observe Medical and fuel both our near-

Observe Medical ASA – Signs agreement with the intention to acquire Sylak AB

Observe Medical ASA, October 16, 2020: Observe Medical ASA (the "Company" or "Observe Medical") has signed a non-binding term sheet including an exclusive right to acquire 100% of the shares in Sylak AB (“Sylak”), a Swedish private limited company, for an agreed enterprise value of SEK 6 million (on a cash and debt free basis) from ABIGO Medical AB (“ABIGO Medical”). The contemplated acquisition will significantly strengthen Observe Medical’s commercial organization and corresponding go-to-market execution power in the Nordics. Sylak is a distributor of ICU/anesthesia products in the

Observe Medical ASA: Registration of share capital increase following exercise of employee share options

Oslo, 4 September 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 31 August 2020 regarding the exercise of employee share options and issue of 171,875 new shares in the Company. The NOK 44,687.50 share capital increase pertaining to the exercise of the employee share options has now been registered with the Norwegian Register of Business Enterprises. The new share capital of the Company is NOK 5,097,418.82 divided into 19,605,457 shares, each with a par value of NOK 0.26. For further information, please contact: Björn Larsson, CEO,

Observe Medical ASA: Exercise of share options, resolution to increase the share capital and mandatory notification of trade

Oslo, 31 August 2020: The board of directors of Observe Medical ASA (the "Company") has resolved to increase the share capital of the Company following the completion of an exercise period for vested share options. 1. Exercise of employee share options In total 171,875 employee share options were exercised, giving the option holders the right to subscribe for in total 171,875 new shares, each with a par value of NOK 0.26. The option holders were granted the options in connection with the demerger and transfer of Navamedic ASA’s Medtech division to Observe Medical ASA on 31 October

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe